Sigma Square Capital
Overview
Sigma Square Capital is a venture capital firm that focuses on growth-stage investments in the TMT, healthcare, consumption upgrade, and fintech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| WeRide | Sep 2017 | Pre Seed | - |
| Waytous | Mar 2020 | Series A Extension | Co-investor |
| Beijing Biosis Healing Biological Technology | Jan 2019 | Series C | Co-investor |
| ABclonal | Feb 2021 | Series C | Co-investor |
Key People
Peter Zhang
Founding Managing Partner
Kun Ouyang
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sigma Square Capital based?
Sigma Square Capital is headquartered in Beijing, Beijing, China.
When was Sigma Square Capital founded?
Sigma Square Capital was founded in 2015.
How many portfolio companies does Sigma Square Capital have?
Sigma Square Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Sigma Square Capital's portfolio?
Portfolio companies visible on Caplight include WeRide, Waytous, Beijing Biosis Healing Biological Technology, ABclonal.
What was Sigma Square Capital's most recent investment shown here?
Sigma Square Capital's most recent investment in this portfolio sample was in ABclonal in 2021.
What sectors does Sigma Square Capital focus on?
Sigma Square Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Sigma Square Capital focus on?
Sigma Square Capital typically invests at the Early stage.
What is Sigma Square Capital's AUM?
Sigma Square Capital's assets under management are estimated between $50.0M and $100.0M.